The global medical imaging market hit a massive $45.5 billion in 2026 [1], marking a total structural shift toward AI-native ...

This collaboration enhances QT Imaging's Cloud SaaS Platform by integrating Olea Medical's advanced visualization, quantitative analytics and AI-ready imaging technologies to support clinical ...

DMedical announced today that it raised more than $100 million (AU$150 million) through a new institutional placement.

Oncology Imaging AI Strategy Pulse 2025-2032: Pathways, Platforms & Playbooks is a global deep-dive on how cancer imaging AI is actually being bought, deployed, and scaled across health systems, OEMs, ...

QT Imaging data will be enabled for clinical interpretation by incorporating Olea Medical’s analytics technologies.

New 3D imaging solution brings Avatar Medical’s 3D visualization software and Barco’s glasses-free 3D display together, transforming the patient consultation into a shared, real-time experience. Using ...

Creates a fully-connected, cloud-first imaging ecosystem spanning high-growth outpatient and ambulatory, teleradiology and hospital settings Brings AI and workflow orchestration, cloud PACS, and image ...

For up to 30% of patients who are allergic to medical contrast dye or have a dye restriction because of other health conditions, they might find that it takes longer to get a diagnosis when it comes ...

Eyas Medical Imaging is currently scaling up operations with plans to commercialise the system in the US later this year.

NYU Grossman School of Medicine’s Vilcek Institute of Graduate Biomedical Sciences offers PhD training in biomedical imaging.